CVS Health Corporation (CVS) stock prices updated...
 

CVS Health Corporation stock price

CVS Health Corporation latest news:


  • 11/14/2017 11:41:09

    Amazon homing in on medical devices/supplies, not pharma: Jefferies

    The possibility of online retailer Amazon.com Inc. entering the pharmaceutical industry has sent the stocks of drug distributors and pharmacy-benefit managers quaking in recent months, but a new report from Jefferies analysts suggests that Amazon is instead homing for the medical devices and supplies industries. Correspondence between two state pharmacy boards and Amazon reveals that those state licenses can only be used for medical device and supplies distribution, the Jefferies report said, based on information that was obtained through a Freedom of Information Act request. This direction was likely chosen to avoid "the more comprehensive regulatory requirements associated with the Wholesale Drug Distribution Act," Jefferies analyst Brian Tanquilut said. That has created an overhang on stocks like AmerisourceBergen Corp. , Cardinal Health Inc. , McKesson Corp. , Express Scripts Holding Co. , CVS Health Corp. and Walgreens Boots Alliance Inc. ; "Unfortunately, we believe only time will refute these investor concerns," he said. Amazon shares have surged 15% over the last three months, compared with a 4.5% rise in the S&P 500 and a 6.6% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/06/2017 14:48:46

    UPDATE 1-Drug distributor McKesson to buy CVS's specialty distribution unit

    Nov 6 (Reuters) - Drug distributor McKesson Corp said on Monday it would buy drugstore operator CVS Health Corp's specialty distribution unit in a deal valued at $735 million in cash.

  • 11/06/2017 14:18:42

    CVS to offer nationwide next-day delivery in preemptive shot at Amazon

    CVS Health plans to begin offering next-day delivery of prescriptions from its nationwide network of more than 9,700 stores.        

  • 11/06/2017 10:38:40

    UPDATE 3-CVS to start next-day delivery as Amazon threat looms

    Nov 6 (Reuters) - U.S. drugstore chain CVS Health Corp said on Monday it would start next-day delivery from its stores in 2018, a move some analysts said was in response to Amazon.com's potential entry into prescription drug sales.

  • 11/06/2017 09:05:19

    Why Solid CVS Health Earnings Are Not Enough


  • 11/03/2017 13:15:35

    CVS, Aetna aim to finalize deal as early as December: sources

    NEW YORK (Reuters) - U.S. pharmacy operator CVS Health Corp and health insurer Aetna Inc are working toward finalizing merger terms and announcing a deal for more than $70 billion as early as December, according to people familiar with the matter.

  • 10/27/2017 15:25:47

    CVS deal for Aetna could help retailer face Amazon entry: analysts

    (Reuters) - U.S. pharmacy operator CVS Health Corp's move to buy health insurer Aetna Inc could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said.

  • 10/27/2017 15:21:02

    UPDATE 1-CVS deal for Aetna could help retailer face Amazon entry - analysts

    Oct 27 (Reuters) - U.S. pharmacy operator CVS Health Corp's move to buy health insurer Aetna Inc could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said.

  • 10/27/2017 14:39:00

    Here's Why CVS Health Is Tumbling 6.8% Today

    A big and costly deal could be brewing for this retail pharmacy chain.

  • 10/26/2017 17:59:55

    CVS makes more than $66 billion bid for Aetna: sources

    (Reuters) - U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday.

  • 10/26/2017 17:56:00

    UPDATE 3-CVS makes more than $66 billion bid for Aetna -sources

    Oct 26 (Reuters) - U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday.

  • 10/26/2017 15:51:31

    CVS makes more than $66 billion bid for Aetna: source

    (Reuters) - U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, a person familiar with the matter said on Thursday.

  • 10/26/2017 15:39:42

    Aetna's stock surges on report of CVS deal talks

    Aetna's stock has surged after a news report said CVS Health is in talks to buy the insurer a deal that could be worth more than $60 billion.

  • 10/26/2017 15:25:46

    Aetna shares soar of report of potential acquisition by CVS Health

    A deal for pharmacy giant CVS to buy Aetna for more than 200 per share would value the health insurer at more than $66 billion, report says        

  • 10/26/2017 14:26:28

    CVS makes bid for Aetna: source

    (Reuters) - U.S pharmacy operator CVS Health Corp has made an offer to acquire U.S. health insurer Aetna Inc for more than $200 per share, a person familiar with the matter said on Thursday.

  • 10/26/2017 14:09:02

    CVS Health in talks to buy health insurer Aetna: WSJ

    (Reuters) - Drug retailer CVS Health Corp is in talks to buy health insurer Aetna Inc , the Wall Street Journal reported on Thursday, citing sources.

  • 10/26/2017 14:05:22

    CVS Health in talks to buy health insurer Aetna - WSJ

    Drug retailer CVS Health Corp (CVS) is in talks to buy health insurer Aetna Inc (AET), the Wall Street Journal reported on Thursday, citing sources. Aetna's shares closed up 11.5 percent at $178.60, after hitting $184.98. CVS Health's (CVS) stock closed down 2.9 percent at $73.31. Aetna had a market cap of $53.2 billion as of Wednesday's close, according to Thomson Reuters data.

  • 10/26/2017 14:05:07

    Dow, S&P 500 close higher; biotech weakness pressures Nasdaq

    The Dow and S&P 500 ended higher on Thursday, supported by a steady stream of healthy earnings, though weakness in the biotechnology sector pressured the Nasdaq. The Dow Jones Industrial Average rose 71 points, or 0.3%, to 23,401. The S&P 500 added 3.3 points to 2,560, a gain of 0.1%. The Nasdaq Composite Index ended down 7 points, or 0.1%, at 6,557. The Nasdaq's weakness came as biotech shares sold off sharply. The iShares Nasdaq Biotechnology ETF lost 2.3% after Celgene Corp. reported disappointing results and cut its outlook. Celgene shares ended 16% lower. On the upside, Twitter Inc. rose 20% on the back of its results while Ford Motor Co. ended up 1%. The stocks of companies in the pharmaceutical supply chain dropped after a report that Amazon has obtained approval to become a wholesale distributor in a number of states. Rite Aid Corp. sank 6.2% while CVS Health Corp. was down 2.9%. CVS shares were also impacted by reports it would buy Aetna . Shares of Aetna ended 11.5% higher. Adding to the buying momentum, the House of Representatives passed a budget blueprint on Thursday, paving the way for the Senate to later pass a tax-reform package.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 10/26/2017 14:01:00

    CVS Health is in Talks to Buy Aetna: Sources

    A blockbuster pharma-health insurance deal is in the works.

  • 10/26/2017 13:51:59

    BRIEF-CVS Health in talks to buy Aetna - CNBC, citing DJ ‍​

    ‍​. * CVS Health (CVS) in talks to buy Aetna - CNBC, citing DJ ‍​.

  • 10/26/2017 13:04:42

    Drug stocks drop after report that Amazon has obtained pharmacy licenses

    The stocks of companies in the pharmaceutical supply chain dropped in Thursday afternoon trade after a report by the St. Louis Post-Dispatch that online retailer Amazon has obtained approval to become a wholesale distributor in a number of states. Amazon has received approval in at least 12 states, the St. Louis Post-Dispatch reported. Speculation about an Amazon pharmacy entry has swirled since a CNBC report on the subject earlier this year, but Amazon has repeatedly declined to comment on or confirm any interest in pharmacy. Such a move would likely threaten a number of industry players, including drug wholesalers, pharmacy chains and pharmacy-benefit managers, middlemen that negotiate drug prices. Rite Aid Corp. shares dropped 5.6% in Thursday afternoon trade, CVS Health Corp. shares dropped 4.8%, Express Scripts Holding Company shares dropped 3.5%, McKesson Corp. shares dropped 3.4%, AmerisourceBergen Corp. shares dropped 4.4%, Walgreens Boots Alliance shares dropped 3.7% and Cardinal Health Inc. shares dropped 2.5%, compared with a 0.2% rise in the S&P 500 . Many of the stocks have plunged in the last several months on concerns about Amazon. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 10/24/2017 15:28:54

    BRIEF-CVS Health introduces new PBM performance-based pharmacy network

    CVS Health Corp(CVS). * CVS Health(CVS) introduces new PBM performance-based pharmacy network focused on reducing costs and improving clinical outcomes.

  • More trends:

    Cypress Energy PartnersCELP | CYS InvestmentsCYS | CYS InvestmentsCYS^A | CYS InvestmentsCYS^B | Cytec Industries Inc.CYT | D.R. HortonDHI | Dana Holding CorporationDAN | Danaher CorporationDHR | Danaos CorporationDAC | DAQO New Energy Corp.DQ |